Abiopharma

🔍 Bulis Veronica Sanchez (Executive)

Company: Lyell Immunopharma, Inc. (LYEL)

Report Date: 2025-12-24

Detailed Transactions and Holdings:

• Sold 1,136 shares of Common Stock at $38.67 per share (Direct)
  Date: 2025-12-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,077.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 936 shares of Common Stock at $32.32 per share (Direct)
  Date: 2025-12-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,141.00 | transaction_form_type: 4

Footnotes:

• F1: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $38.6643 to $38.6751 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.